BACKGROUND AND OBJECTIVE:There is remarkable alteration in hypertension prevalence and awareness, and their correlates among various geographic locations and ethnic groups. The aim of this study was to report hypertension prevalence, awareness, and its correlates as well as hypertension treatment, and control among Azari people aged 35 years and older.MATERIALS AND METHODS:The pilot phase of the Azar Cohort Study; a state level of a nationwide PERSIAN cohort study was conducted in Khameneh city between October 2014 and January 2015. All people 35 years of age and above were invited to take part in this study. A comprehensive range of different biomarkers, lifestyle, socioeconomic factors, and health-related factors was collected. Blood pressure was measured by a trained nurse/midwife. Descriptive statistical methods were used to present general characteristics of the study population as frequency tables. Separate multiple logistic regression models were built to assess the predictors of hypertension prevalence.RESULTS:A total of 1038 people were included in this study. The overall prevalence of hypertension was 22.9%. Awareness of hypertension was 60.5% and in those with known hypertension, 84% were using the antihypertensive medications, of those 68.5% had controlled hypertension. After adjustment; age (odds ratios [OR]adj= 1.12 95% confidence interval [CI]: 1.09–1.15), gender (ORadj= 1.65 95% CI: 1.08–2.51), obesity ORadj= 2.51 (1.40–4.88), waist-to-hip ratio (WHR) (ORadj= 1.70 (1.05–2.75), and comorbidities (ORadj= 2.51 (1.72–3.66) were independent predictors of hypertension.CONCLUSION:Age, sex, body mass index, WHR, and comorbidities were known as predictors of hypertension in this study, health promotion strategies including lifestyle modification to reduce overweight/obesity and secondary prevention programs for early detection of hypertension in high-risk groups according to age, gender, and disease profile are recommended.

Background Despite the current endeavors in the prevention and treatment of diabetes, it is, still, one of the leading causes of mortality, morbidity, and health system costs worldwide. The aim of this study was to determine the prevalence of pre-/diabetes, awareness, treatment, and control of diabetes and its correlates among people participating in the pilot phase of the Azar cohort study in the Northwest of Iran.Methods A total of 1038 adults aged 35 years and older in Khamene city, East Azerbaijan province, Northwest of Iran, were recruited for the pilot phase of Azar cohort; a province-level of a nationwide PERSIAN cohort study. A comprehensive questionnaire including sociodemographic and clinical information was completed, and biological samples were collected. The quantities of HbA1C and FBS were adopted as benchmarks for assessing the status of subjects about having diabetes and pre-diabetes. All analyses were performed using STATA (version 14), the statistical software.Results The overall prevalence of diabetes and pre-diabetes was 18.2% and 34.8%, respectively. The result of the multivariate regression model showed, females had a better awareness (2.00 (CI: 0.94–4.26)), and their reception of diabetes’ medicine was higher: 2.57 (CI: 1.25–5.29). Having at least one comorbid condition was associated with an increased awareness of diabetes (3.13 (CI: 1.47–6.66)); in addition, here, the possibility of receiving medication was,also, higher: 4.54 (CI: 2.21–9.32). Furthermore, people who were smokers had a lower awareness. There was a significant increase in diabetes’ control among people with secondary and high school education (2.4 (CI: 0.92–6.23).Conclusions The current study demonstrated the increased prevalence of pre-/diabetes as well as low awareness, inadequate treatment and control. More effective and corrective factors in reducing the risk of diabetes and its control require more attention.

No abstract